查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1463134

食慾抑制剂市场、占有率、规模、趋势、行业分析报告：依药物类别、依给药途径、依最终用户、依地区、依细分市场、预测，2024-2032年

Anorexiants Market Share, Size, Trends, Industry Analysis Report, By Drug Class (Catecholamines, Serotonin); By Route of Administration; By End User; By Region; Segment Forecast, 2024 - 2032
出版日期: | 出版商: Polaris Market Research | 英文 118 Pages | 商品交期: 最快1-2个工作天内

价格

根据Polaris Market Research的最新研究，到2032年，全球食慾抑制剂市场规模预计将达到14.0313亿美元。 该研究报告提供了对当前市场动态的详细洞察，并对未来市场成长进行了分析。

全球食慾抑制剂市场的成长很大程度上是由于消费者对体重管理的兴趣日益浓厚，这在某种程度上限制了食慾。 一类抑制食慾药物的出现引发了消费者的兴趣，并提高了作为控制热量摄取手段的需求。 这是药厂提高产能的动力。 例如，2024年2月，Novo Holdings宣布策略以165亿美元收购Catalent，以加速减重註射液Wegovy和糖尿病注射剂Ozempic的供应。

由于未来患有肥胖症的人数将大幅增加，研究期间市场对食慾管理药物的需求将会很大。 根据世界肥胖联合会2023年报告，预计到2035年，约有400万人（占世界人口的50%以上）患有肥胖症。

能量消耗与体力活动消耗的能量之间的差距不断扩大是导致肥胖率上升的一个因素。 社群媒体使用的增加促使更多的人选择改变以身体为中心的生活方式，这刺激了对食慾抑制剂等药物的需求。 2023 年的一项研究发现，TikTok 和 Instagram 对美国有色人种年轻人的体重管理教育有很大影响力。

肥胖族群中心臟骤停、第二型糖尿病和某些癌症等慢性疾病的盛行率引起了向医生咨询治疗的消费者的关注，以及在医疗机构中使用食慾抑制剂等肥胖抑制剂的关注。 科罗拉多大学博尔德分校 2023 年的一项研究发现，肥胖会使死亡风险增加，低至 22%，高至 91%。 另一项研究发现，当肥胖成年人透过饮食和体力活动减轻体重 5% 至 10% 时，他们罹患心血管疾病的风险就会降低。

越来越多的研究集中在治疗肥胖和体重管理的新药物配方创新上，预计这表明世界上对食慾抑制剂的需求量很大。 例如，2023年11月，美国食品药物管理局（FDA）宣布核准慢性体重管理注射药物Zepbound（替泽帕肽）。 2024 年 1 月，礼来公司宣布计划明年将其肥胖药物 Mounjaro 引进印度。

食慾抑制剂市场报告重点

由于儿茶酚胺产业在促进能源消耗方面的有效表现，预计未来几年将出现最高成长。

由于给药的便利性，口服药物领域占了最大的市场占有率。

由于医院为肥胖患者提供治疗，因此预计医院部门将获得更大的收入占有率。

由于肥胖盛行率不断上升，预计亚太地区将在预测期内实现最快的成长。

目录

第一章简介

第 2 章执行摘要

第三章研究方法

第四章全球食慾抑制剂市场洞察

  • 食慾抑制剂市场 - 最终用户快照
  • 食慾抑制剂市场动态
    • 推动者和机会
      • 体力活动少
      • 对减肥药物的需求不断增加
    • 抑制因素和课题
      • 监管障碍和副作用
  • PESTEL 分析
  • 食慾抑制剂市场终端用户趋势
  • 价值链分析
  • 新冠肺炎 (COVID-19) 影响分析

第 5 章依药物类别划分的世界市场

  • 主要发现
  • 简介
  • 儿茶酚胺
  • 血清素

第 6 章依管理途径划分的全球市场

  • 主要发现
  • 简介
  • 口头
  • 皮下

第 7 章最终用户的全球市场

  • 主要发现
  • 简介
  • 业务销售
  • 医院
  • 诊所
  • 零售销售
  • 网路药局
  • 邮购药房

第 8 章依地区划分的世界市场

  • 主要发现
  • 简介
    • 2019-2032 年依地区划分的食慾抑制剂市场评估
  • 食慾抑制剂市场 - 北美
    • 北美：食慾抑制剂市场，依药物类别，2019-2032 年
    • 北美：食慾抑制剂市场，以最终用户划分，2019-2032 年
    • 北美：2019-2032 年食慾抑制剂市场（依给药途径）
    • 食慾抑制剂市场－美国
    • 食慾抑制剂市场 - 加拿大
  • 食慾抑制剂市场 - 欧洲
    • 欧洲：食慾抑制剂市场，依药物类别，2019-2032 年
    • 欧洲：食慾抑制剂市场，以最终使用者划分，2019-2032 年
    • 欧洲：2019-2032 年食慾抑制剂市场（依给药途径）
    • 食慾抑制剂市场 - 英国
    • 食慾抑制剂市场 - 法国
    • 食慾抑制剂市场 - 德国
    • 食慾抑制剂市场－义大利
    • 食慾抑制剂市场 - 西班牙
    • 食慾抑制剂市场 - 荷兰
    • 食慾抑制剂市场 - 俄罗斯
  • 食慾抑制剂市场 - 亚太地区
    • 亚太地区：食慾抑制剂市场，依药物类别，2019-2032 年
    • 亚太地区：2019-2032 年最终使用者的食慾抑制剂市场
    • 亚太地区：食慾抑制剂市场，依给药途径划分，2019-2032 年
    • 食慾抑制剂市场 - 中国
    • 食慾抑制剂市场 - 印度
    • 食慾抑制剂市场 - 马来西亚
    • 食慾抑制剂市场－日本
    • 食慾抑制剂市场－印度尼西亚
    • 食慾抑制剂市场－韩国
  • 食慾抑制剂市场 - 中东和非洲
    • 中东和非洲：2019-2032 年食慾抑制剂市场（依药物类别）
    • 中东和非洲：2019-2032 年最终用户的食慾抑制剂市场
    • 中东和非洲：2019-2032 年食慾抑制剂市场（依给药途径）
    • 食慾抑制剂市场 - 沙乌地阿拉伯
    • 食慾抑制剂市场 - 阿联酋
    • 食慾抑制剂市场 - 以色列
    • 食慾抑制剂市场 - 南非
  • 食慾抑制剂市场 - 拉丁美洲
    • 拉丁美洲：食慾抑制剂市场，依药物类别，2019-2032 年
    • 拉丁美洲：食慾抑制剂市场，依最终用户划分，2019-2032 年
    • 拉丁美洲：食慾抑制剂市场，依给药途径划分，2019-2032 年
    • 食慾抑制剂市场 - 墨西哥
    • 食慾抑制剂市场 - 巴西
    • 食慾抑制剂市场－阿根廷

第九章竞争态势

  • 扩张与收购分析
    • 放大
    • 收购
  • 合作/协作/合约/出版物

第十章公司简介

  • AstraZeneca（UK）
  • Aurobindo Pharma（India）
  • Bausch Health Companies Inc.（Canada）
  • Cipla Inc.（US）
  • Currax Pharmaceuticals LLC（US）
  • Eisai Co., Ltd.（Japan）
  • F. Hoffmann-La Roche Ltd.（Switzerland）
  • GlaxoSmithKline plc（UK）
  • Johnson & Johnson Private Limited（US）
  • Lannett（US）
  • Merck & Co., Inc.（US）
  • Mylan N.V.（US）
  • Novartis AG（Switzerland）
Product Code: PM4793

The global anorexiants market size is expected to reach USD 1,403.13 million by 2032, according to a new study by Polaris Market Research. The report "Anorexiants Market Share, Size, Trends, Industry Analysis Report, By Drug Class (Catecholamines, Serotonin); By Route of Administration; By End User; By Region; Segment Forecast, 2024 - 2032" gives a detailed insight into current market dynamics and provides analysis on future market growth.

The growth of the global anorexiants market is highly attributable to the rising consumer interest in weight management, which, in a way, limits appetite. The availability of the class of drugs that suppress appetite is gaining consumers attention as a measure to control calorie intake, creating higher demand. This is driving the pharmaceutical companies to enhance their production capacity. For instance, in February 2024, Novo Holdings unveiled its strategy to acquire Catalent to promote the supply of Wegovy, a weight loss injection, and Ozempic, a diabetic shot, for $16.5 billion.

As the number of people suffering from obesity grows significantly in the future, there will be a huge demand for appetite management drugs in the marketplace during the study period. According to the World Obesity Federation Report 2023, about 4 million people, which is more than 50% of the global population, are estimated to be obese by 2035.

The growing gap between energy consumption and energy spent on physical activities is the building factor leading to the rise in obesity. The increase in the number of people opting for lifestyle modification, with a higher focus on body look due to the growing use of social media, is stimulating the demand for appetite-control medications, such as anorexiants. A 2023 study found that TikTok and Instagram have a significant influence in educating weight management among youth of color in the United States.

The prevalence of chronic diseases, such as cardiac arrest, type 2 diabetes, and certain cancers, among obese people is grabbing the attention of consumers to consult doctors for treatment, facilitating the need for obese medications, including anorexiants, in healthcare settings. According to the University of Colorado Boulder Research in 2023, obesity increases the risk of death from a minimum of 22% to a maximum of 91%. According to another study, losing weight by 5-10% with diet and physical activities among obese people lowered the risk of developing cardiovascular disease among obese adults.

The growing research studies focusing on the innovation of new medication formulations for the treatment of obesity and weight management are anticipated to showcase significant demand for anorexiants in the world. For instance, in November 2023, the U.S. Food and Drug Administration (FDA) announced the approval of a chronic weight management injection, Zepbound (tirzepatide). In January 2024, Eli Lilly announced its plan to introduce the obesity drug Mounjaro in India in the next year.

Anorexiants Market Report Highlights

The catecholamines segment is anticipated to witness the highest growth in the coming years due to its effective performance in boosting energy expenditure.

Oral segment accounted for the largest market share owing to its convenience in taking medication.

The hospitals segment is projected to experience a larger revenue share due to the presence of hospitals offering treatment for obese patients.

Asia Pacific is projected to register the fastest growth during the forecast period, attributable to the increasing incidence of obesity.

The global players include AstraZeneca, Aurobindo Pharma, Bausch Health Companies Inc., Cipla Inc., Currax Pharmaceuticals LLC, & Eisai Co., Ltd.

Polaris Market Research has segmented the anorexiants market report based on drug class, route of administration, end user and region:

Anorexiants, Drug Class Outlook (Revenue - USD Million, 2019 - 2032)

  • Catecholamines
  • Serotonin

Anorexiants, Route of Admission Outlook (Revenue - USD Million, 2019 - 2032)

  • Oral
  • Subcutaneous

Anorexiants, End User Outlook (Revenue - USD Million, 2019 - 2032)

  • Institutional sales
  • Hospitals
  • Clinics
  • Retail sales
  • Online pharmacies
  • Mail Order Pharmacies

Anorexiants, Regional Outlook (Revenue - USD Million, 2019 - 2032)

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Netherlands
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Indonesia
  • Malaysia
  • Australia
  • Rest of Asia Pacific
  • Latin America
  • Argentina
  • Brazil
  • Mexico
  • Rest of Latin America
  • Middle East & Africa
  • UAE
  • Saudi Arabia
  • Israel
  • South Africa
  • Rest of Middle East & Africa

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Sources
    • 3.2.1. Primary Sources
    • 3.2.2. Secondary Sources

4. Global Anorexiants Market Insights

  • 4.1. Anorexiants Market - End User Snapshot
  • 4.2. Anorexiants Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. The presence of lower physical activity in the population
      • 4.2.1.2. Increase in the demand for weight-loss drugs
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. Regulatory hurdles and side effects
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTEL Analysis
  • 4.5. Anorexiants Market End User Trends
  • 4.6. Value Chain Analysis
  • 4.7. COVID-19 Impact Analysis

5. Global Anorexiants Market, by Drug Class

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Anorexiants Market, by Drug Class, 2019-2032 (USD Million)
  • 5.3. Catecholamines
    • 5.3.1. Global Anorexiants Market, by Catecholamines, by Region, 2019-2032 (USD Million)
  • 5.4. Serotonin
    • 5.4.1. Global Anorexiants Market, by Serotonin, by Region, 2019-2032 (USD Million)

6. Global Anorexiants Market, by Route of Admission

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Anorexiants Market, by Route of Admission, 2019-2032 (USD Million)
  • 6.3. Oral
    • 6.3.1. Global Anorexiants Market, by Oral, by Region, 2019-2032 (USD Million)
  • 6.4. Subcutaneous
    • 6.4.1. Global Anorexiants Market, by Subcutaneous, by Region, 2019-2032 (USD Million)

7. Global Anorexiants Market, by End User

  • 7.1. Key Findings
  • 7.2. Introduction
    • 7.2.1. Global Anorexiants Market, by End User, 2019-2032 (USD Million)
  • 7.3. Institutional sales
    • 7.3.1. Global Anorexiants Market, by Institutional sales, By Region, 2019-2032 (USD Million)
  • 7.4. Hospitals
    • 7.4.1. Global Anorexiants Market, by Hospitals, By Region, 2019-2032 (USD Million)
  • 7.5. Clinics
    • 7.5.1. Global Anorexiants Market, by Clinics, By Region, 2019-2032 (USD Million)
  • 7.6. Retail sales
    • 7.6.1. Global Anorexiants Market, by Retail sales, By Region, 2019-2032 (USD Million)
  • 7.7. Online pharmacies
    • 7.7.1. Global Anorexiants Market, by Online pharmacies, By Region, 2019-2032 (USD Million)
  • 7.8. Mail Order Pharmacies
    • 7.8.1. Global Anorexiants Market, by Mail Order Pharmacies, By Region, 2019-2032 (USD Million)

8. Global Anorexiants Market, by Geography

  • 8.1. Key findings
  • 8.2. Introduction
    • 8.2.1. Anorexiants Market Assessment, By Geography, 2019-2032 (USD Million)
  • 8.3. Anorexiants Market - North America
    • 8.3.1. North America: Anorexiants Market, by Drug Class, 2019-2032 (USD Million)
    • 8.3.2. North America: Anorexiants Market, by End User, 2019-2032 (USD Million)
    • 8.3.3. North America: Anorexiants Market, by Route of Admission, 2019-2032 (USD Million)
    • 8.3.4. Anorexiants Market - U.S.
      • 8.3.4.1. U.S.: Anorexiants Market, by Drug Class, 2019-2032 (USD Million)
      • 8.3.4.2. U.S.: Anorexiants Market, by End User, 2019-2032 (USD Million)
      • 8.3.4.3. U.S.: Anorexiants Market, by Route of Admission, 2019-2032 (USD Million)
    • 8.3.5. Anorexiants Market - Canada
      • 8.3.5.1. Canada: Anorexiants Market, by Drug Class, 2019-2032 (USD Million)
      • 8.3.5.2. Canada.: Anorexiants Market, by End User, 2019-2032 (USD Million)
      • 8.3.5.3. Canada: Anorexiants Market, by Route of Admission, 2019-2032 (USD Million)
  • 8.4. Anorexiants Market - Europe
    • 8.4.1. Europe: Anorexiants Market, by Drug Class, 2019-2032 (USD Million)
    • 8.4.2. Europe.: Anorexiants Market, by End User, 2019-2032 (USD Million)
    • 8.4.3. Europe: Anorexiants Market, by Route of Admission, 2019-2032 (USD Million)
    • 8.4.4. Anorexiants Market - UK
      • 8.4.4.1. UK: Anorexiants Market, by Drug Class, 2019-2032 (USD Million)
      • 8.4.4.2. UK.: Anorexiants Market, by End User, 2019-2032 (USD Million)
      • 8.4.4.3. UK: Anorexiants Market, by Route of Admission, 2019-2032 (USD Million)
    • 8.4.5. Anorexiants Market - France
      • 8.4.5.1. France: Anorexiants Market, by Drug Class, 2019-2032 (USD Million)
      • 8.4.5.2. France.: Anorexiants Market, by End User, 2019-2032 (USD Million)
      • 8.4.5.3. France: Anorexiants Market, by Route of Admission, 2019-2032 (USD Million)
    • 8.4.6. Anorexiants Market - Germany
      • 8.4.6.1. Germany: Anorexiants Market, by Drug Class, 2019-2032 (USD Million)
      • 8.4.6.2. Germany.: Anorexiants Market, by End User, 2019-2032 (USD Million)
      • 8.4.6.3. Germany: Anorexiants Market, by Route of Admission, 2019-2032 (USD Million)
    • 8.4.7. Anorexiants Market - Italy
      • 8.4.7.1. Italy: Anorexiants Market, by Drug Class, 2019-2032 (USD Million)
      • 8.4.7.2. Italy.: Anorexiants Market, by End User, 2019-2032 (USD Million)
      • 8.4.7.3. Italy: Anorexiants Market, by Route of Admission, 2019-2032 (USD Million)
    • 8.4.8. Anorexiants Market - Spain
      • 8.4.8.1. Spain: Anorexiants Market, by Drug Class, 2019-2032 (USD Million)
      • 8.4.8.2. Spain.: Anorexiants Market, by End User, 2019-2032 (USD Million)
      • 8.4.8.3. Spain: Anorexiants Market, by Route of Admission, 2019-2032 (USD Million)
    • 8.4.9. Anorexiants Market - Netherlands
      • 8.4.9.1. Netherlands: Anorexiants Market, by Drug Class, 2019-2032 (USD Million)
      • 8.4.9.2. Netherlands.: Anorexiants Market, by End User, 2019-2032 (USD Million)
      • 8.4.9.3. Netherlands: Anorexiants Market, by Route of Admission, 2019-2032 (USD Million)
    • 8.4.10. Anorexiants Market - Russia
      • 8.4.10.1. Russia: Anorexiants Market, by Drug Class, 2019-2032 (USD Million)
      • 8.4.10.2. Russia.: Anorexiants Market, by End User, 2019-2032 (USD Million)
      • 8.4.10.3. Russia: Anorexiants Market, by Route of Admission, 2019-2032 (USD Million)
  • 8.5. Anorexiants Market - Asia Pacific
    • 8.5.1. Asia Pacific: Anorexiants Market, by Drug Class, 2019-2032 (USD Million)
    • 8.5.2. Asia Pacific.: Anorexiants Market, by End User, 2019-2032 (USD Million)
    • 8.5.3. Asia Pacific: Anorexiants Market, by Route of Admission, 2019-2032 (USD Million)
    • 8.5.4. Anorexiants Market - China
      • 8.5.4.1. China: Anorexiants Market, by Drug Class, 2019-2032 (USD Million)
      • 8.5.4.2. China.: Anorexiants Market, by End User, 2019-2032 (USD Million)
      • 8.5.4.3. China: Anorexiants Market, by Route of Admission, 2019-2032 (USD Million)
    • 8.5.5. Anorexiants Market - India
      • 8.5.5.1. India: Anorexiants Market, by Drug Class, 2019-2032 (USD Million)
      • 8.5.5.2. India.: Anorexiants Market, by End User, 2019-2032 (USD Million)
      • 8.5.5.3. India: Anorexiants Market, by Route of Admission, 2019-2032 (USD Million)
    • 8.5.6. Anorexiants Market - Malaysia
      • 8.5.6.1. Malaysia: Anorexiants Market, by Drug Class, 2019-2032 (USD Million)
      • 8.5.6.2. Malaysia.: Anorexiants Market, by End User, 2019-2032 (USD Million)
      • 8.5.6.3. Malaysia: Anorexiants Market, by Route of Admission, 2019-2032 (USD Million)
    • 8.5.7. Anorexiants Market - Japan
      • 8.5.7.1. Japan: Anorexiants Market, by Drug Class, 2019-2032 (USD Million)
      • 8.5.7.2. Japan.: Anorexiants Market, by End User, 2019-2032 (USD Million)
      • 8.5.7.3. Japan: Anorexiants Market, by Route of Admission, 2019-2032 (USD Million)
    • 8.5.8. Anorexiants Market - Indonesia
      • 8.5.8.1. Indonesia: Anorexiants Market, by Drug Class, 2019-2032 (USD Million)
      • 8.5.8.2. Indonesia.: Anorexiants Market, by End User, 2019-2032 (USD Million)
      • 8.5.8.3. Indonesia: Anorexiants Market, by Route of Admission, 2019-2032 (USD Million)
    • 8.5.9. Anorexiants Market - South Korea
      • 8.5.9.1. South Korea: Anorexiants Market, by Drug Class, 2019-2032 (USD Million)
      • 8.5.9.2. South Korea.: Anorexiants Market, by End User, 2019-2032 (USD Million)
      • 8.5.9.3. South Korea: Anorexiants Market, by Route of Admission, 2019-2032 (USD Million)
  • 8.6. Anorexiants Market - Middle East & Africa
    • 8.6.1. Middle East & Africa: Anorexiants Market, by Drug Class, 2019-2032 (USD Million)
    • 8.6.2. Middle East & Africa.: Anorexiants Market, by End User, 2019-2032 (USD Million)
    • 8.6.3. Middle East & Africa: Anorexiants Market, by Route of Admission, 2019-2032 (USD Million)
    • 8.6.4. Anorexiants Market - Saudi Arabia
      • 8.6.4.1. Saudi Arabia: Anorexiants Market, by Drug Class, 2019-2032 (USD Million)
      • 8.6.4.2. Saudi Arabia.: Anorexiants Market, by End User, 2019-2032 (USD Million)
      • 8.6.4.3. Saudi Arabia: Anorexiants Market, by Route of Admission, 2019-2032 (USD Million)
    • 8.6.5. Anorexiants Market - UAE
      • 8.6.5.1. UAE: Anorexiants Market, by Drug Class, 2019-2032 (USD Million)
      • 8.6.5.2. UAE.: Anorexiants Market, by End User, 2019-2032 (USD Million)
      • 8.6.5.3. UAE: Anorexiants Market, by Route of Admission, 2019-2032 (USD Million)
    • 8.6.6. Anorexiants Market - Israel
      • 8.6.6.1. Israel: Anorexiants Market, by Drug Class, 2019-2032 (USD Million)
      • 8.6.6.2. Israel.: Anorexiants Market, by End User, 2019-2032 (USD Million)
      • 8.6.6.3. Israel: Anorexiants Market, by Route of Admission, 2019-2032 (USD Million)
    • 8.6.7. Anorexiants Market - South Africa
      • 8.6.7.1. South Africa: Anorexiants Market, by Drug Class, 2019-2032 (USD Million)
      • 8.6.7.2. South Africa.: Anorexiants Market, by End User, 2019-2032 (USD Million)
      • 8.6.7.3. South Africa: Anorexiants Market, by Route of Admission, 2019-2032 (USD Million)
  • 8.7. Anorexiants Market - Latin America
    • 8.7.1. Latin America: Anorexiants Market, by Drug Class, 2019-2032 (USD Million)
    • 8.7.2. Latin America.: Anorexiants Market, by End User, 2019-2032 (USD Million)
    • 8.7.3. Latin America: Anorexiants Market, by Route of Admission, 2019-2032 (USD Million)
    • 8.7.4. Anorexiants Market - Mexico
      • 8.7.4.1. Mexico: Anorexiants Market, by Drug Class, 2019-2032 (USD Million)
      • 8.7.4.2. Mexico.: Anorexiants Market, by End User, 2019-2032 (USD Million)
      • 8.7.4.3. Mexico: Anorexiants Market, by Route of Admission, 2019-2032 (USD Million)
    • 8.7.5. Anorexiants Market - Brazil
      • 8.7.5.1. Brazil: Anorexiants Market, by Drug Class, 2019-2032 (USD Million)
      • 8.7.5.2. Brazil.: Anorexiants Market, by End User, 2019-2032 (USD Million)
      • 8.7.5.3. Brazil: Anorexiants Market, by Route of Admission, 2019-2032 (USD Million)
    • 8.7.6. Anorexiants Market - Argentina
      • 8.7.6.1. Argentina: Anorexiants Market, by Drug Class, 2019-2032 (USD Million)
      • 8.7.6.2. Argentina.: Anorexiants Market, by End User, 2019-2032 (USD Million)
      • 8.7.6.3. Argentina: Anorexiants Market, by Route of Admission, 2019-2032 (USD Million)

9. Competitive Landscape

  • 9.1. Expansion and Acquisition Analysis
    • 9.1.1. Expansion
    • 9.1.2. Acquisitions
  • 9.2. Partnerships/Collaborations/Agreements/Exhibitions

10. Company Profiles

  • 10.1. AstraZeneca (UK)
    • 10.1.1. Company Overview
    • 10.1.2. Financial Performance
    • 10.1.3. Product Benchmarking
    • 10.1.4. Recent Development
  • 10.2. Aurobindo Pharma (India)
    • 10.2.1. Company Overview
    • 10.2.2. Financial Performance
    • 10.2.3. Product Benchmarking
    • 10.2.4. Recent Development
  • 10.3. Bausch Health Companies Inc. (Canada)
    • 10.3.1. Company Overview
    • 10.3.2. Financial Performance
    • 10.3.3. Product Benchmarking
    • 10.3.4. Recent Development
  • 10.4. Cipla Inc. (US)
    • 10.4.1. Company Overview
    • 10.4.2. Financial Performance
    • 10.4.3. Product Benchmarking
    • 10.4.4. Recent Development
  • 10.5. Currax Pharmaceuticals LLC (US)
    • 10.5.1. Company Overview
    • 10.5.2. Financial Performance
    • 10.5.3. Product Benchmarking
    • 10.5.4. Recent Development
  • 10.6. Eisai Co., Ltd. (Japan)
    • 10.6.1. Company Overview
    • 10.6.2. Financial Performance
    • 10.6.3. Product Benchmarking
    • 10.6.4. Recent Development
  • 10.7. F. Hoffmann-La Roche Ltd. (Switzerland)
    • 10.7.1. Company Overview
    • 10.7.2. Financial Performance
    • 10.7.3. Product Benchmarking
    • 10.7.4. Recent Development
  • 10.8. GlaxoSmithKline plc (UK)
    • 10.8.1. Company Overview
    • 10.8.2. Financial Performance
    • 10.8.3. Product Benchmarking
    • 10.8.4. Recent Development
  • 10.9. Johnson & Johnson Private Limited (US)
    • 10.9.1. Company Overview
    • 10.9.2. Financial Performance
    • 10.9.3. Product Benchmarking
    • 10.9.4. Recent Development
  • 10.10. Lannett (US)
    • 10.10.1. Company Overview
    • 10.10.2. Financial Performance
    • 10.10.3. Product Benchmarking
    • 10.10.4. Recent Development
  • 10.11. Merck & Co., Inc. (US)
    • 10.11.1. Company Overview
    • 10.11.2. Financial Performance
    • 10.11.3. Product Benchmarking
    • 10.11.4. Recent Development
  • 10.12. Mylan N.V. (US)
    • 10.12.1. Company Overview
    • 10.12.2. Financial Performance
    • 10.12.3. Product Benchmarking
    • 10.12.4. Recent Development
  • 10.13. Novartis AG (Switzerland)
    • 10.13.1. Company Overview
    • 10.13.2. Financial Performance
    • 10.13.3. Product Benchmarking
    • 10.13.4. Recent Development

List of Tables

  • Table 1 Global Anorexiants Market, by Drug Class, 2019-2032 (USD Million)
  • Table 2 Global Anorexiants Market, by Route of Admission, 2019-2032 (USD Million)
  • Table 3 Global Anorexiants Market, by End User, 2019-2032 (USD Million)
  • Table 4 Anorexiants Market Assessment, By Geography, 2019-2032 (USD Million)
  • Table 5 North America: Anorexiants Market, by Drug Class, 2019-2032 (USD Million)
  • Table 6 North America: Anorexiants Market, by Route of Admission, 2019-2032 (USD Million)
  • Table 7 North America: Anorexiants Market, by End User, 2019-2032 (USD Million)
  • Table 8 U.S.: Anorexiants Market, by Drug Class, 2019-2032 (USD Million)
  • Table 9 U.S.: Anorexiants Market, by Route of Admission, 2019-2032 (USD Million)
  • Table 10 U.S.: Anorexiants Market, by End User, 2019-2032 (USD Million)
  • Table 11 Canada: Anorexiants Market, by Drug Class, 2019-2032 (USD Million)
  • Table 12 Canada: Anorexiants Market, by Route of Admission, 2019-2032 (USD Million)
  • Table 13 Canada: Anorexiants Market, by End User, 2019-2032 (USD Million)
  • Table 14 Europe: Anorexiants Market, by Drug Class, 2019-2032 (USD Million)
  • Table 15 Europe: Anorexiants Market, by Route of Admission, 2019-2032 (USD Million)
  • Table 16 Europe: Anorexiants Market, by End User, 2019-2032 (USD Million)
  • Table 17 UK: Anorexiants Market, by Drug Class, 2019-2032 (USD Million)
  • Table 18 UK: Anorexiants Market, by Route of Admission, 2019-2032 (USD Million)
  • Table 19 UK: Anorexiants Market, by End User, 2019-2032 (USD Million)
  • Table 20 France: Anorexiants Market, by Drug Class, 2019-2032 (USD Million)
  • Table 21 France: Anorexiants Market, by Route of Admission, 2019-2032 (USD Million)
  • Table 22 France: Anorexiants Market, by End User, 2019-2032 (USD Million)
  • Table 23 Germany: Anorexiants Market, by Drug Class, 2019-2032 (USD Million)
  • Table 24 Germany: Anorexiants Market, by Route of Admission, 2019-2032 (USD Million)
  • Table 25 Germany: Anorexiants Market, by End User, 2019-2032 (USD Million)
  • Table 26 Italy: Anorexiants Market, by Drug Class, 2019-2032 (USD Million)
  • Table 27 Italy: Anorexiants Market, by Route of Admission, 2019-2032 (USD Million)
  • Table 28 Italy: Anorexiants Market, by End User, 2019-2032 (USD Million)
  • Table 29 Spain: Anorexiants Market, by Drug Class, 2019-2032 (USD Million)
  • Table 30 Spain: Anorexiants Market, by Route of Admission, 2019-2032 (USD Million)
  • Table 31 Spain: Anorexiants Market, by End User, 2019-2032 (USD Million)
  • Table 32 Netherlands: Anorexiants Market, by Drug Class, 2019-2032 (USD Million)
  • Table 33 Netherlands: Anorexiants Market, by Route of Admission, 2019-2032 (USD Million)
  • Table 34 Netherlands: Anorexiants Market, by End User, 2019-2032 (USD Million)
  • Table 35 Russia: Anorexiants Market, by Drug Class, 2019-2032 (USD Million)
  • Table 36 Russia: Anorexiants Market, by Route of Admission, 2019-2032 (USD Million)
  • Table 37 Russia: Anorexiants Market, by End User, 2019-2032 (USD Million)
  • Table 38 Asia Pacific: Anorexiants Market, by Drug Class, 2019-2032 (USD Million)
  • Table 39 Asia Pacific: Anorexiants Market, by Route of Admission, 2019-2032 (USD Million)
  • Table 40 Asia Pacific: Anorexiants Market, by End User, 2019-2032 (USD Million)
  • Table 41 China: Anorexiants Market, by Drug Class, 2019-2032 (USD Million)
  • Table 42 China: Anorexiants Market, by Route of Admission, 2019-2032 (USD Million)
  • Table 43 China: Anorexiants Market, by End User, 2019-2032 (USD Million)
  • Table 44 India: Anorexiants Market, by Drug Class, 2019-2032 (USD Million)
  • Table 45 India: Anorexiants Market, by Route of Admission, 2019-2032 (USD Million)
  • Table 46 India: Anorexiants Market, by End User, 2019-2032 (USD Million)
  • Table 47 Malaysia: Anorexiants Market, by Drug Class, 2019-2032 (USD Million)
  • Table 48 Malaysia: Anorexiants Market, by Route of Admission, 2019-2032 (USD Million)
  • Table 49 Malaysia: Anorexiants Market, by End User, 2019-2032 (USD Million)
  • Table 50 Japan: Anorexiants Market, by Drug Class, 2019-2032 (USD Million)
  • Table 51 Japan: Anorexiants Market, by Route of Admission, 2019-2032 (USD Million)
  • Table 52 Japan: Anorexiants Market, by End User, 2019-2032 (USD Million)
  • Table 53 Indonesia: Anorexiants Market, by Drug Class, 2019-2032 (USD Million)
  • Table 54 Indonesia: Anorexiants Market, by Route of Admission, 2019-2032 (USD Million)
  • Table 55 Indonesia: Anorexiants Market, by End User, 2019-2032 (USD Million)
  • Table 56 South Korea: Anorexiants Market, by Drug Class, 2019-2032 (USD Million)
  • Table 57 South Korea: Anorexiants Market, by Route of Admission, 2019-2032 (USD Million)
  • Table 58 South Korea: Anorexiants Market, by End User, 2019-2032 (USD Million)
  • Table 59 Middle East & Africa: Anorexiants Market, by Drug Class, 2019-2032 (USD Million)
  • Table 60 Middle East & Africa: Anorexiants Market, by Route of Admission, 2019-2032 (USD Million)
  • Table 61 Middle East & Africa: Anorexiants Market, by End User, 2019-2032 (USD Million)
  • Table 62 Saudi Arabia: Anorexiants Market, by Drug Class, 2019-2032 (USD Million)
  • Table 63 Saudi Arabia: Anorexiants Market, by Route of Admission, 2019-2032 (USD Million)
  • Table 64 Saudi Arabia: Anorexiants Market, by End User, 2019-2032 (USD Million)
  • Table 65 UAE: Anorexiants Market, by Drug Class, 2019-2032 (USD Million)
  • Table 66 UAE: Anorexiants Market, by Route of Admission, 2019-2032 (USD Million)
  • Table 67 UAE: Anorexiants Market, by End User, 2019-2032 (USD Million)
  • Table 68 Israel: Anorexiants Market, by Drug Class, 2019-2032 (USD Million)
  • Table 69 Israel: Anorexiants Market, by Route of Admission, 2019-2032 (USD Million)
  • Table 70 Israel: Anorexiants Market, by End User, 2019-2032 (USD Million)
  • Table 71 South Africa: Anorexiants Market, by Drug Class, 2019-2032 (USD Million)
  • Table 72 South Africa: Anorexiants Market, by Route of Admission, 2019-2032 (USD Million)
  • Table 73 South Africa: Anorexiants Market, by End User, 2019-2032 (USD Million)
  • Table 74 Latin America: Anorexiants Market, by Drug Class, 2019-2032 (USD Million)
  • Table 75 Latin America: Anorexiants Market, by Route of Admission, 2019-2032 (USD Million)
  • Table 76 Latin America: Anorexiants Market, by End User, 2019-2032 (USD Million)
  • Table 77 Mexico: Anorexiants Market, by Drug Class, 2019-2032 (USD Million)
  • Table 78 Mexico: Anorexiants Market, by Route of Admission, 2019-2032 (USD Million)
  • Table 79 Mexico: Anorexiants Market, by End User, 2019-2032 (USD Million)
  • Table 80 Brazil: Anorexiants Market, by Drug Class, 2019-2032 (USD Million)
  • Table 81 Brazil: Anorexiants Market, by Route of Admission, 2019-2032 (USD Million)
  • Table 82 Brazil: Anorexiants Market, by End User, 2019-2032 (USD Million)
  • Table 83 Argentina: Anorexiants Market, by Drug Class, 2019-2032 (USD Million)
  • Table 84 Argentina: Anorexiants Market, by Route of Admission, 2019-2032 (USD Million)
  • Table 85 Argentina: Anorexiants Market, by End User, 2019-2032 (USD Million)

List of Figures

  • Figure 1. Global Anorexiants Market, 2019-2032 (USD Million)
  • Figure 2. Integrated Ecosystem
  • Figure 3. Research Methodology: Top-Down & Bottom-Up Approach
  • Figure 4. Market by Geography
  • Figure 5. Porter's Five Forces
  • Figure 6. Market by Route of Admission
  • Figure 7. Global Anorexiants Market, by Route of Admission, 2022 & 2032 (USD Million)
  • Figure 8. Market by Drug Class
  • Figure 9. Global Anorexiants Market, by Drug Class, 2022 & 2032 (USD Million)
  • Figure 10. Market by End User
  • Figure 11. Global Anorexiants Market, by End User, 2022 & 2032 (USD Million)
  • Figure 12. Anorexiants Market Assessment, By Geography, 2019-2032 (USD Million)
  • Figure 13. Strategic Analysis - Anorexiants Market